Bank of America’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bank of America’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-290,617	Closed	-$5.8M	–	8768
2022 Q3	$5.8M	Buy	290,617 +179,506	+162%	+$2.37M	﹤0.01%	3184
2022 Q2	$766K	Sell	111,111 -19,308	-15%	-$136K	﹤0.01%	5129
2022 Q1	$1.21M	Sell	130,419 -2,732	-2%	-$29.1K	﹤0.01%	5059
2021 Q4	$1.89M	Buy	133,151 +124,654	+1,467%	+$2.16M	﹤0.01%	4618
2021 Q3	$197K	Buy	8,497 +59	+0.7%	+$1.4K	﹤0.01%	6326
2021 Q2	$210K	Sell	8,438 -22,606	-73%	-$607K	﹤0.01%	6067
2021 Q1	$870K	Buy	31,044 +29,275	+1,655%	+$1.06M	﹤0.01%	4958
2020 Q4	$62K	Buy	1,769 +866	+96%	+$37.7K	﹤0.01%	6236
2020 Q3	$45K	Buy	+903	New	+$36.5K	﹤0.01%	6055

Bank of America's FMTX Position: Q4 2022 in Review

Bank of America sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 290,617 shares — an estimated $5.8M sold.

Bank of America first reported a position in FMTX in Q3 2020 and held it in 9 quarters. The position peaked at $5.8M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Bank of America reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Bank of America sold 290,617 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $5.8M.
Bank of America first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
Bank of America's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $5.8M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.